Skip to main content
Clinical Trials/NCT05736614
NCT05736614
Recruiting
N/A

Efficacy of a PrEP Uptake & Adherence Intervention Among Male Sex Workers Using a 2-stage Randomization Design

Brown University5 sites in 1 country500 target enrollmentNovember 3, 2022
ConditionsPrevention

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prevention
Sponsor
Brown University
Enrollment
500
Locations
5
Primary Endpoint
Stage one: PrEP initiation
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)

Detailed Description

A theory-based, manualized intervention -called "PrEPare for Work"-includes two separate but complementary interventions that address MSW-specific behavioral, economic, interpersonal \& structural-level barriers to accessing and adhering to PrEP: 1) peer-led, strengths-based case management (SBCM) for PrEP linkage and uptake; and 2) a technology and counseling intervention to optimize PrEP adherence (once they have access to PrEP). This research will test the PrEPare for Work intervention in a fully-powered RCT to assess efficacy and cost-effectiveness.

Registry
clinicaltrials.gov
Start Date
November 3, 2022
End Date
June 2026
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Stage one: PrEP initiation

Time Frame: 2-month post Stage 1 randomization

Stage one: PrEP initiation will be measured via verification of prescription filled within two months post-randomization, associated medical records from a PrEP prescriber, and self-report.

Stage two: PrEP adherence

Time Frame: 12-month post Stage 2 randomization

Stage two: PrEP adherence will be measured via tenofovir concentration in hair. Self-reported adherence will supplement biological monitoring data at 4-month intervals.

Secondary Outcomes

  • PrEP persistence(12-month post Stage 2 randomization)

Study Sites (5)

Loading locations...

Similar Trials